欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/2119/002
药品名称Imipenem/Cilastatin Kabi 500 mg/500 mg powder for solution for infusion
活性成分
    • cilastatin sodium salt 250.0 mg
    • imipenem monohydrate 250.0 mg
剂型Powder for solution for infusion
上市许可持有人FRESENIUS KABI LIMITED
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Germany (DE)
    • United Kingdom (Northern Ireland) (XI)
      PL 08828/0190 - 0022 + PL 08828/0185 - 0018
    • Netherlands (NL)
    • Luxembourg (LU)
    • Austria (AT)
      Imipenem/Cilastatin Kabi 500 mg/500 mg Pulver zur Herstellung einer Infusionslösung
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Poland (PL)
      Imipenem / Cilastatin Kabi
    • Hungary (HU)
    • Czechia (CZ)
      IMIPENEM/CILASTATIN KABI 250 MG/250 MG
    • Slovakia (SK)
    • Romania (RO)
      Imipenem/Cilastatin Kabi 500 mg/500 mg pulbere pentru soluţie perfuzabilă
    • Ireland (IE)
    • Bulgaria (BG)
    • Estonia (EE)
    • Slovenia (SI)
许可日期2009/07/16
最近更新日期2024/06/13
药物ATC编码
    • J01DH51 imipenem and cilastatin
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase